ITMCTR2000003155
Not yet recruiting
未知
A randomized controlled trial for the clinical effect of Wu-Mei-Wan Decoction in the treatment of primary hypertension with upper heat and lower cold syndrome
Affiliated Hospital of Shandong University of TCM0 sitesTBD
ConditionsEssential hypertension
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Essential hypertension
- Sponsor
- Affiliated Hospital of Shandong University of TCM
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Patients, who were diagnosed with the criteria of essential hypertension, who belonged to the types of upper heat and lower cold syndrome,who after the lifestyle intervention,and diagnosed the upper heat and lower cold syndrome of essential hypertension grade I;
- •(2\) In the past 2 weeks, the blood pressure was stable, without the treatment of traditional Chinese medicine or proprietary Chinese medicine, without the treatment of western medicine or after the treatment of western medicine, the blood pressure was still in hypertensive grade 1 patients;
- •(3\) aged 18\-75 years old;
- •(4\) Volunteer to participate in the experiment and sign the informed consent, and cooperate with various investigations and tests.
Exclusion Criteria
- •1\. secondary hypertension, refractory hypertension, malignant hypertension, acute and subacute hypertension, white coat hypertension and unstable blood pressure;
- •2\. pregnant and lactating women, women of child\-bearing age do not agree to use contraceptive measures during the experiment;
- •3\. Have mental illness, can't cooperate very well;
- •4\. confirmed to have serious heart disease, severe neurosis and heart, liver, kidney insufficiency;
- •5\. With severe endocrine, hematopoietic system, liver, kidney and other primary diseases, malignant tumors, mental patients;
- •6\. Uncorrected hyperthyroidism, hypothyroidism; Patients with nephrotic syndrome, diabetes mellitus and acute hepatobiliary disease;
- •7\. people who have suffered from serious cerebrovascular accidents, heart diseases, severe trauma, major surgery and other primary diseases with unstable general conditions and poor prognosis within 6 months;
- •8\. Data were collected on cases of other diseases that were under medical treatment and affected experimental drug observers;
- •9\. those who have participated in clinical trials of other drugs within three months;
- •10\. Other conditions that the researchers considered inappropriate for inclusion were eliminated.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A comparison of success rate of two rood canal sealer used in root canal treatmentKCT0006230Yonsei University Health System, Dental Hospital164
Completed
Phase 3
A randomized controlled trial about clinical effect of closed subcutaneous suction drainage and subcuticular suture against surgical site infection in gastroenterological surgeryGastric cancer, Colorectal cancer, Liver cancer, Biliary tract cancer, inflammatory bowel diseaseJPRN-UMIN000003073Shinshu University, Department of Surgery160
Completed
Not Applicable
Randomized controlled trial of 4-hour versus 24-hour nasogastric rehydration in children with acute gastroenteritis and moderate dehydratioAcute viral gastroenteritis with moderate dehydrationOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12610000737033Royal Children's Hospital Melbourne426
Recruiting
Not Applicable
A comparative prospective randomized clinical study of Premixed Endocem and ProRoot MTA as root-end filling materials in endodontic surgery.KCT0007084Yonsei University Health System, Dental Hospital80
Completed
Not Applicable
Randomized, controlled trial of the clinical effect of selecrive SGLT2 blocker, ipragliflozin, and DPP-4 blocker in type 2 diabetic patients with NAFLD/NASH.- multicenter studytype 2 diabetic patients with NAFLD/NASHJPRN-UMIN000015727Saga University55